Univest
Univest
  • Markets

Sastasundar Ventures Share Price Forecast to 2030

  • July 27, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Sastasundar Ventures Share Price Forecast to 2030

Sastasundar Ventures share price Rs 251.00. 52W high Rs 298.00, low Rs 166.00. Market cap Rs 10961Cr. Cr. 2030 scenario range Rs 188.25 to Rs 451.80.

Sastasundar Ventures operates an online pharmacy and health services platform, one of India’s earlier digital health players. As a listed player in the Information Technology segment, Sastasundar Ventures’s share price trajectory over the next three years will be shaped by rising demand for online pharmacy and digital health services. Understanding the interplay of these growth drivers and risk factors is essential for investors evaluating this stock.

Table of Contents

Toggle
  • Sastasundar Ventures Share Price Today and Key Metrics
  • Key Factors Driving Sastasundar Ventures Share Price
  • Risk Factors to Watch
  • Sastasundar Ventures Share Price Forecast: 3-Year Scenarios
  • Investor Considerations for Sastasundar Ventures
  • How to Evaluate Sastasundar Ventures Share Price Performance
  • Frequently Asked Questions: Sastasundar Ventures Share Price
    • What is Sastasundar Ventures’s share price today?
    • What is the Sastasundar Ventures share price forecast for the next 3 years?
    • Is Sastasundar Ventures a good stock to buy for the long term?
    • What factors drive Sastasundar Ventures share price?
    • What are the risks of investing in Sastasundar Ventures?
    • What is Sastasundar Ventures’s P/E ratio?
    • How does Sastasundar Ventures compare to its peers?

Sastasundar Ventures Share Price Today and Key Metrics

Metric Value
Current Price ₹251.00
52-Week High / Low ₹298 – ₹166
Market Cap ₹ 10,961 Cr.
P/E Ratio 105
Book Value ₹ 73.0
Return on Equity (ROE) 3.43 %
Return on Capital Employed (ROCE) 5.57 %
Dividend Yield 0.00 %

Sastasundar Ventures is currently trading at ₹251.00. The stock has a 52-week range of ₹298 – ₹166, reflecting the price band within which it has moved over the past year. The current P/E ratio of 105 provides a baseline for valuation comparison with peers in the Information Technology space.

Log in to Univest to access stock insights and portfolio tracking for Sastasundar Ventures.

Key Factors Driving Sastasundar Ventures Share Price

The primary growth catalyst for Sastasundar Ventures is rising demand for online pharmacy and digital health services. This driver is anchored in structural trends within the Information Technology sector, which remains a focus area for domestic institutional investors and analysts tracking India’s growth story.

Sector peers including Medico Remedies, Morepen Laboratories, Park Medi World operate in similar addressable markets and provide useful benchmarks for valuation and growth trajectories. Monitoring these peers alongside Sastasundar Ventures’s own quarterly disclosures offers a more complete picture of the competitive landscape.

Risk Factors to Watch

Investors in Sastasundar Ventures must account for the following: intense competition from larger online pharmacy players and ongoing operating losses make profitability visibility challenging. These risks are not unique to Sastasundar Ventures and affect the broader Information Technology segment, but the degree to which they impact Sastasundar Ventures specifically depends on its balance sheet strength, client diversification, and management execution.

Sastasundar Ventures Share Price Forecast: 3-Year Scenarios

The following indicative scenario analysis is based on illustrative assumptions and is not a research-grade price target. Actual outcomes will depend on company performance, sector dynamics, and macroeconomic conditions.

Scenario 3-Year Indicative Range Key Assumptions
Bull Case ₹451.80 Strong execution on growth plans, sector tailwinds materialise, margin expansion driven by operating leverage
Base Case ₹338.85 Steady growth broadly in line with sector, manageable input cost pressures and stable demand conditions
Bear Case ₹188.25 Demand slowdown, margin compression from rising costs, or sector-specific headwinds materialise

These ranges are illustrative only and do not constitute research or investment advice. The bull case assumes the key growth drivers materialise fully, while the bear case reflects meaningful headwinds. The base case represents a more moderate, sector-average outcome.

Consult a SEBI-registered investment adviser before making any investment decisions in this stock.

Investor Considerations for Sastasundar Ventures

Before investing in Sastasundar Ventures, consider the following: First, assess the company’s competitive moat within the Information Technology segment. Second, evaluate the balance sheet quality, specifically the debt-to-equity ratio and coverage ratios. Third, track the management’s guidance on growth and margins in recent investor communications.

The Information Technology index provides a sector benchmark to assess whether Sastasundar Ventures is outperforming or underperforming its peers on a risk-adjusted basis. Retail investors are always advised to compare multiple data points, including Screener.in fundamentals, NSE filings, and SEBI disclosures, before forming an investment view.

Download the Univest app for real-time stock data, research, and portfolio management.

How to Evaluate Sastasundar Ventures Share Price Performance

Assessing the Sastasundar Ventures share price over a multi-year horizon requires tracking both company-specific and sector-level indicators. Key metrics that typically correlate with share price movement in the Information Technology segment include revenue growth, operating margin trajectory, return on capital employed, and balance sheet leverage. Investors tracking the Sastasundar Ventures share price should monitor these across quarterly filings.

The 52-week high and low of the Sastasundar Ventures share price provide a useful anchoring range for near-term valuation assessment. A share price trading close to its 52-week low may reflect sector headwinds or company-specific stress, while a share price near its 52-week high could suggest strong momentum or overextension relative to fundamentals. Neither extreme is a buy or sell signal on its own.

Comparing the Sastasundar Ventures share price trend with peers in the same sector, and with the relevant sector index, helps investors understand whether underperformance or outperformance is idiosyncratic or part of a broader sectoral move. This relative analysis is a core part of any disciplined share price evaluation framework.

Frequently Asked Questions: Sastasundar Ventures Share Price

What is Sastasundar Ventures’s share price today?

As of the latest available data, Sastasundar Ventures (SASTASUNDR) is trading at ₹251.00 on the NSE. The 52-week range is ₹298 – ₹166. For real-time prices, check the Univest app or NSE website.

What is the Sastasundar Ventures share price forecast for the next 3 years?

A specific share price projection for Sastasundar Ventures over the next three years depends on revenue growth, margin improvement and sector conditions. Investors should track quarterly results and consult a SEBI-registered adviser for personalised analysis.

Is Sastasundar Ventures a good stock to buy for the long term?

Sastasundar Ventures operates in the Information Technology sector. Long-term investment decisions should be based on the company’s business fundamentals, competitive positioning, and your individual risk profile and investment horizon.

What factors drive Sastasundar Ventures share price?

Key drivers include rising demand for online pharmacy and digital health services, quarterly earnings results, sector trends in Information Technology, and broader market conditions.

What are the risks of investing in Sastasundar Ventures?

Key risks include intense competition from larger online pharmacy players and ongoing operating losses make profitability visibility challenging. Equity investments carry market risk, and past performance is no guarantee of future results.

What is Sastasundar Ventures’s P/E ratio?

Sastasundar Ventures’s current price-to-earnings ratio is 105. Comparing this with sector peers in the Information Technology space helps assess relative valuation.

How does Sastasundar Ventures compare to its peers?

Sastasundar Ventures competes with players such as Medico Remedies, Morepen Laboratories in the Information Technology segment. Peer comparisons on revenue growth, margin profile and valuation multiples are useful inputs before making any investment decision.

Disclaimer: This article is for educational and informational purposes only. It does not constitute financial advice or a recommendation to buy, sell, or hold any security. Investing in equities involves risk, including the possible loss of principal. Past performance is not indicative of future results. Please consult a SEBI-registered research analyst or investment adviser before making investment decisions. Research Analyst: SEBI Registration No. INH000013776. Investment Adviser: INA000017639. Stock Broker: INZ000317437.


News
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply